American International Group’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,442
Closed -$12.5K 1673
2024
Q1
$12.5K Sell
1,442
-14
-1% -$95 ﹤0.01% 2970
2023
Q4
$9.54K Sell
1,456
-39
-3% -$252 ﹤0.01% 3012
2023
Q3
$14.9K Sell
1,495
-99
-6% -$1.09K ﹤0.01% 3009
2023
Q2
$19.8K Sell
1,594
-40
-2% -$540 ﹤0.01% 3019
2023
Q1
$22.9K Sell
1,634
-47
-3% -$675 ﹤0.01% 2879
2022
Q4
$24.1K Sell
1,681
-39
-2% -$614 ﹤0.01% 2900
2022
Q3
$44K Buy
1,720
+6
+0.4% +$151 ﹤0.01% 2843
2022
Q2
$49K Sell
1,714
-370
-18% -$11.7K ﹤0.01% 2866
2022
Q1
$74K Buy
2,084
+1
+0% +$34 ﹤0.01% 2703
2021
Q4
$87K Buy
2,083
+89
+4% +$3.6K ﹤0.01% 2778
2021
Q3
$98K Buy
1,994
+399
+25% +$19.5K ﹤0.01% 2818
2021
Q2
$67 Buy
1,595
+285
+22% +$11K ﹤0.01% 2961
2021
Q1
$47 Buy
+1,310
New +$43.4K ﹤0.01% 2999

Other funds holding MRVI

American International Group's MRVI Position: Q2 2024 in Review

American International Group sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 1,442 shares — an estimated $12.5K sold.

American International Group first reported a position in MRVI in Q1 2021 and held it in 13 quarters. The position peaked at $98K in Q3 2021. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

  • American International Group reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 1,442 Maravai LifeSciences shares in Q2 2024, an estimated $12.5K.
  • American International Group first reported a position in Maravai LifeSciences in Q1 2021 and held it in 13 quarters.
  • American International Group's Maravai LifeSciences position peaked at $98K in Q3 2021.
  • 206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.